Neonc Technologies (NASDAQ:NTHI) Raised to Strong-Buy at BTIG Research

Neonc Technologies (NASDAQ:NTHI) was upgraded by analysts at BTIG Research to a “strong-buy” rating in a note issued to investors on Friday,Zacks.com reports.

NTHI has been the topic of a number of other reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Neonc Technologies in a research note on Friday, March 27th. Zacks Research raised shares of Neonc Technologies to a “hold” rating in a research note on Wednesday, January 14th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $15.00.

Neonc Technologies Stock Down 0.2%

NASDAQ:NTHI opened at $4.78 on Friday. Neonc Technologies has a fifty-two week low of $3.20 and a fifty-two week high of $12.99. The firm’s fifty day simple moving average is $7.59 and its 200-day simple moving average is $8.66.

Insider Activity at Neonc Technologies

In other Neonc Technologies news, President Amir F. Heshmatpour acquired 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 23rd. The shares were acquired at an average cost of $4.90 per share, for a total transaction of $49,000.00. Following the transaction, the president directly owned 3,052,000 shares of the company’s stock, valued at approximately $14,954,800. This represents a 0.33% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In the last 90 days, insiders have bought 60,700 shares of company stock valued at $336,790.

Institutional Investors Weigh In On Neonc Technologies

Several institutional investors and hedge funds have recently made changes to their positions in the business. Bank of America Corp DE boosted its position in shares of Neonc Technologies by 1.0% in the 3rd quarter. Bank of America Corp DE now owns 226,486 shares of the company’s stock worth $2,056,000 after buying an additional 2,207 shares in the last quarter. Westmount Partners LLC boosted its position in shares of Neonc Technologies by 7.7% in the 4th quarter. Westmount Partners LLC now owns 43,320 shares of the company’s stock worth $358,000 after buying an additional 3,112 shares in the last quarter. State Street Corp boosted its position in shares of Neonc Technologies by 9.9% in the 4th quarter. State Street Corp now owns 43,170 shares of the company’s stock worth $357,000 after buying an additional 3,900 shares in the last quarter. Barclays PLC boosted its position in shares of Neonc Technologies by 5,314.8% in the 4th quarter. Barclays PLC now owns 9,151 shares of the company’s stock worth $76,000 after buying an additional 8,982 shares in the last quarter. Finally, Foundations Investment Advisors LLC purchased a new stake in shares of Neonc Technologies in the 3rd quarter worth about $100,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.